Loading…
www.wellerectile.com was cited for unlawfully selling unapproved and misbranded drug products over the internet to U.S. consumers, including products claiming to treat, prevent, diagnose, or cure COVID-19 and malaria in violation of sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The company's products lacked FDA approval or authorization and were introduced into interstate commerce without meeting required safety and efficacy standards. The enforcement action was issued during the COVID-19 public health emergency, when the FDA prioritized protecting consumers from unauthorized treatments for the disease.